Marked Elevation of Serum Interleukin-6 in Patients With Cholangiocarcinoma

Abstract

In selected patients, a high serum level of IL-6 marks patients with CC and correlates with tumor burden both before and after resection. IL-6 levels are elevated in patients with other liver neoplasms and may distinguish patients with hepatic malignancies from those with benign disease.